Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Pathology Oncology Research : POR|July 14, 2022
A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia CellsKunlong Zhang, Li Gao, Jianwei Wang, et al.
Cancer Cell International|April 23, 2021
BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genesShuiyan Wu, You Jiang, Yi Hong, et al.
Annals of Hematology|October 20, 2025
Frequent TCR rearrangements in pediatric B-cell lymphoblastic acute leukemia: genomic and phenotypic featuresJiajia Zheng, Yiting Wang, Zhiheng Li, et al.
Clinical Transplantation|February 10, 2026
Association of CYP2C19 Single Nucleotide Polymorphism With Hemorrhagic Cystitis After Pediatric Allogeneic Hematopoietic Stem Cell TransplantationWeiliang Zhang, Qi Ji, Qingwei Wang, et al.
Frontiers in Immunology|August 6, 2025
Impact of cyclosporine A-related single nucleotide polymorphisms on post-transplant outcomes in pediatric hematologic malignancy patients undergoing allogeneic hematopoietic stem cell transplantationQi Ji, Senlin Zhang, Minyuan Liu, et al.
Cancer Biology & Therapy|September 28, 2022
BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genesLi Ma, Jianwei Wang, Yongping Zhang, et al.
Journal of Immunology Research|August 12, 2022
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid LeukemiaXu Sang, Yongping Zhang, Fang Fang, et al.
Hematology (Amsterdam, Netherlands)|August 18, 2023
BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3Li Ma, Jianwei Wang, Yang Yang, et al.
Journal of Intensive Medicine|February 14, 2023
Clinical significance of serum IgM and IgG levels in COVID-19 patients in Hubei Province, ChinaZhenjiang Bai, Qing Li, Qinghui Chen, et al.
Haematologica|April 24, 2025
S-adenosylmethionine addiction confers sensitivity to methionine restriction in <i>KMT2A</i>-rearranged acute lymphoblastic leukemiaTrisha Tee, Titine J J Ruiter, Shuiyan Wu, et al.
Pageof 6